Facebook Linkedin Twitter

Non-small cell lung cancer

Brain tumour, illustration
News & Features

Combination Targeted Therapy Improves Pediatric Glioma Outcomes

Malorye Branca -
0
Lung cancer, close-up, NSCLC
News & Features

NSCLC Outcomes Significantly Improved with Immunotherapy Treatments Given Before and After Surgery

Chris Anderson -
0
PD-1 Antibody Targeting Immune Checkpoint Inhibitor
News & Features

Merck Bets Big on ADCs with $4B+ Daiichi Sankyo Deal

Malorye Branca -
0
cancer
News & Features

BMS Acquires KRAS Targeter Mirati in $4.8B Deal

Malorye Branca -
0
cancer cells, illustration
News & Features

Neoadjuvant Checkpoint Inhibitor Use Has Untapped Research Benefits Says New Review

Malorye Branca -
0
Lung cancer, illustration
Molecular Dx

Liquid Biopsy Shows Promise to Identify NSCLC Patients That Will Benefit from Radiation

Chris Anderson -
0
Lung cancer, illustration
News & Features

Combination Immunotherapy More Effective in Neoadjuvant NSCLC

Chris Anderson -
0
Inmunologically active proteins on a T-cell: T-cell receptor, CD-4, CD-28, PD-1 and CTLA-4 and a calcium channel. Cancer Immunotherapy
News & Features

CheckMate 227 Trial Shows Long-Term Dual Immunotherapy Benefits in Advanced NSCLC

Chris Anderson -
0
Middle Eastern appearance male oncologist talking to an older Black Female Patient about Claudin18.2 related CAR T cell and cancer vaccine therapies.
News & Features

OSE Immunotherapeutics Unveils Promising Phase III Cancer Vaccine Results

Alisa Kirkin -
0
antibodies
News & Features

Charging to the Frontline

Chris Anderson -
0
123...9Page 1 of 9

Related Content

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine